Authorized generics offer the exact same drug as brand-name medications - same ingredients, same manufacturer - but at generic prices. Ideal for patients sensitive to formulation changes, they’re a safer, smarter switch than traditional generics.
Expired inhalers, eye drops, and topical medications can be dangerous or ineffective. Learn how to safely dispose of them, why using them is risky, and where to get help if you can’t afford replacements.
Barrett’s Esophagus increases cancer risk, but modern ablation techniques like RFA and cryoablation can prevent progression. Learn who needs treatment, what options exist, and how to reduce your risk.
Portal vein thrombosis is a serious but treatable condition. Early diagnosis and anticoagulation can prevent complications and restore blood flow to the liver. Learn who should be treated, which drugs work best, and how to avoid deadly mistakes.
Medications can impair worker safety or expose employees to dangerous substances. Learn how opioids, chemotherapy drugs, and workplace policies affect health and safety-and what’s being done to protect workers.
The FDA is set to require standardized Patient Medication Information (PMI) for all outpatient prescriptions by 2025. This single-page guide aims to cut medication errors, improve understanding, and make safety info consistent across all pharmacies.
Explains how countries use international reference pricing to set generic drug prices, with examples from Germany, Netherlands, and recent trends. Covers challenges like shortages and innovations like France's dynamic system.
Learn how to manage chronic back pain through physical therapy, safe medications, and daily self-care. Discover proven strategies that reduce pain without opioids, backed by current medical research and real-world data.
Generic medications save money but introduce unique risks like look-alike pills, changing manufacturers, and outdated databases. Learn how pharmacists can prevent and correct these errors using technology, counseling, and simple safety checks.
Brand companies launch authorized generics not to help patients, but to protect profits. These are the exact same drugs as the brand, sold cheaper. Here’s how they use this tactic to beat generic competition and keep revenue flowing.